- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharming Group Nv (PHAR)
Track today's live Pharming (PHAR) share price, performance and key data on this page with our current NASDAQ:PHAR stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Pharming share price on the NASDAQ exchange. Use the dropdown to switch exchange for the PHAR share price, head to our technical summary section, which provides analysis on Pharming share price buy/sell indicators using real-time data (or discuss the Pharming (PHAR) stock price today with other investors in the Pharming NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PHAR share price (ISIN: US71716E1055) to enhance your trading decisions with our free investment tools and resources.
What Is the Pharming Group Nv Share Price Today?
The Pharming share price today is 13.40.
What Is the Stock Symbol for Pharming Group Nv
The stock symbol (or 'ticker') for Pharming Group Nv is "PHAR."
What Stock Exchange Does Pharming Group Nv Trade On?
Pharming Group Nv is listed and trades on the NASDAQ stock exchange.
Is Pharming Group Nv a Good Stock to Buy?
Determining whether Pharming (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PHAR share price (ISIN: US71716E1055) to enhance your trading decisions with our free investment tools and resources.
What Is the Pharming Group Nv Share Price Today?
The Pharming share price today is 13.40.
What Is the Stock Symbol for Pharming Group Nv
The stock symbol (or 'ticker') for Pharming Group Nv is "PHAR."
What Stock Exchange Does Pharming Group Nv Trade On?
Pharming Group Nv is listed and trades on the NASDAQ stock exchange.
Is Pharming Group Nv a Good Stock to Buy?
Determining whether Pharming (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
13.40
+0.18(+1.36%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.92
13.40
52 wk Range
9.11
21.34
PHAR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.9213.40
52 wk Range
9.1121.34
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHAR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
35.10
Upside
+161.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Pharco D receives Investment Bank Analyst Rating Update- Investing.com
Pro
Why is Pharming stock climbing today?- Investing.com
- Pharco D receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 35.10
(+161.94% Upside)
Earnings
Latest Release
27/10/2026
EPS / Forecast
0.30 / 0.16
Revenue / Forecast
117.6M / 103.54M
Compare PHAR to Peers and Sector
Metrics to compare | PHAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHARPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.6x | −1.7x | −0.2x | |
PEG Ratio | 0.00 | 0.06 | 0.00 | |
Price/Book | 3.2x | 1.9x | 2.6x | |
Price / LTM Sales | 2.4x | 4.2x | 2.8x | |
Upside (Analyst Target) | 169.6% | 80.5% | 62.3% | |
Fair Value Upside | Unlock | 9.3% | 8.2% | Unlock |
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Pharming (NASDAQ: PHAR) Share Price Today?
The Pharming stock price today is 13.40 USD.
What Stock Exchange Does Pharming (PHAR) Trade On?
Pharming is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Pharming?
The stock symbol (also called a 'ticker') for Pharming is "PHAR."
What Is the Current Pharming Market Capitalisation?
As of today, Pharming (NASDAQ: PHAR) market cap is 9.48B USD.
What Is Pharming's (PHAR) Earnings Per Share (TTM)?
The Pharming EPS is currently 0.032 (Trailing Twelve Months).
When Is the Next Pharming Earnings Date?
Pharming's next earnings report will be released on 18/03/2027.
Is PHAR a Buy or Sell From a Technical Analyst Perspective?
Based on today's Pharming moving averages and other technical indicators, the daily buy/sell signal for PHAR stock is Strong Buy.
How Many Times Has Pharming Stock Split?
Pharming has split 0 times. (See the PHAR stock split history page for full effective split date and price information.)
How Many Employees Does Pharming Have?
Pharming has 407 employees, based on their latest Companies House report.
What is the current trading status of Pharming (NASDAQ: PHAR)?
As of 11/11/2026, Pharming (PHAR) is trading at a share price of 13.40 USD, with a previous close of 13.22 USD. The stock has fluctuated within a day range of 12.92 USD to 13.40 USD, while its 52-week range spans from 9.11 USD to 21.34 USD.
What Is Pharming (PHAR) Price Target According to Analysts?
The average 12-month price target for Pharming is 35.10 USD, with a high estimate of 41 USD and a low estimate of 23.4 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +161.94% Upside potential.
What Is the PHAR Premarket Price?
PHAR's last pre-market stock price is 12.92 USD. The pre-market share volume is 90.00, and the stock has decreased by -0.30, or -2.27%.
What Is the PHAR After Hours Price?
PHAR's last after hours stock price is 13.12 USD, the stock has decreased by -0.10, or -0.76%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.